Millipore Sigma Vibrant Logo

AGX808 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8)

This E. coli recombinant protein 2019-nCoV Nucleocaspid Recombinant Antigen,full length (Ag-8), Cat. No. AGX808 is tested for use in Lateral Flow Assay.

View Products on Sigmaaldrich.com
AGX808
1 mg  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information
      Description
      Catalogue NumberAGX808
      Description2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8)
      Alternate Names
      • SARS-CoV
      • SARS-CoV-2
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      FormatPurified
      PresentationPurified protein in 10 mM Phosphate buffer, 150 mM NaCl with no preservatives, pH 7.4.
      Quality LevelMQ100
      Applications
      ApplicationThis E. coli recombinant protein 2019-nCoV Nucleocaspid Recombinant Antigen,full length (Ag-8), Cat. No. AGX808 is tested for use in Lateral Flow Assay.
      Key Applications
      • Immunodiffusion
      Application NotesOther recommended antigen products for lateral flow application are AGX804 or AGX806.
      Biological Information
      CloneN/A
      ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      SpecificitySARS CoV-2
      Purification MethodColumn Purification
      UniProt Number
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size1 mg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      AGX808 04061842457854

      Documentation

      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) Certificats d'analyse

      TitreNuméro de lot
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3574427 3574427
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3616501 3616501
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3693110 3693110
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3780591 3780591
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3808747 3808747
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3870086 3870086
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3887110 3887110
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3932139 3932139
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 4015636 4015636
      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 4018477 4018477
      Show more